Immune regulation based on the targeting of early activation molecules

Details for Australian Patent Application No. 2004209984 (hide)

Owner Albor Biologics, Inc.

Inventors Madrid, David Sancho; Artola, Enric Esplugues; Rocamora, Pablo Engel; Alonso, Carlos Martinez; Ramos, Javier Vega; Gomez, Pilar Lauzurica; Sanchez-Madrid, Francisco

Agent Cullens

Pub. Number AU-B-2004209984

PCT Pub. Number WO2004/069183

Priority 200300252 31.01.03 ES; 200302587 05.11.03 ES

Filing date 2 February 2004

Wipo publication date 19 August 2004

Acceptance publication date 5 August 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

15 September 2005 PCT application entered the National Phase

  PCT publication WO2004/069183 Priority application(s): WO2004/069183

5 August 2010 Application Accepted

  Published as AU-B-2004209984

2 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004209985-Methods for treating, preventing and detecting Helicobacter infection

2004209981-Active immunization to generate antibodies to soluble A-beta